WCMNY
MRTX

Westchester Capital Management (New York)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Westchester Capital Management (New York)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90,638
Closed -$5.32M – 290
2023
Q4 		$5.32M Buy
+90,638
New +$5.32M 0.19% 67